市場調查報告書

基因組學市場研究報告:按解決方案/技術/應用/最終用戶行業分析和增長預測(-2030)

Genomics Market Research Report: By Solution, Technology, Application, End User - Global Industry Analysis and Growth Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 968351
出版日期 內容資訊 英文 199 Pages
商品交期: 2-3個工作天內
價格
基因組學市場研究報告:按解決方案/技術/應用/最終用戶行業分析和增長預測(-2030) Genomics Market Research Report: By Solution, Technology, Application, End User - Global Industry Analysis and Growth Forecast to 2030
出版日期: 2020年07月01日內容資訊: 英文 199 Pages
簡介

根據P&S Intelligence進行的研究,全球基因組市場預計將從2019年的182億美元增長到2030年產生680億美元的收入,預測期為2020年。預計2030年將以12.7%的複合年增長率增長)。由於政府的主動性和支持增加,對個性化藥物的需求增加以及測序服務成本降低,該市場正在增長。

本報告調查和分析了全球基因組學市場,並提供了有關市場概況,影響市場增長的因素,市場規模和預測,細分市場分析,競爭條件等的系統信息。我會。

第1章調查背景

  • 調查目的
  • 市場定義
  • 調查範圍
    • 市場細分:按解決方案
    • 市場細分:按技術
    • 市場細分:應用
    • 市場細分:按最終用戶劃分
    • 市場細分:按地區
    • 分析期間
    • 市場數據報告單位
  • 主要利益相關者

第2章調查方法

  • 二次調查
  • 初步調查
  • 基準:調查方法
  • 市場規模估計
  • 數據三角剖分
  • 調查的先決條件

第3章執行摘要

第4章簡介

  • 市場細分的定義
    • 通過解決方案
      • 消耗品
      • 設備
      • 服務
    • 技術
      • PCR
      • 排序
      • 微陣列
      • 其他
    • 按應用
      • 診斷
      • 藥物發現與開發
      • 精準醫學
      • 農業與動物研究
      • 其他
    • 最終用戶
      • 研究中心和學術機構
      • 醫院與診所
      • 製藥與生物技術公司
      • 其他
  • 市場動態
    • 趨勢
      • 收購數量增加
      • 擴大市場進入公司之間的夥伴關係
    • 促進因素
      • 政府的支持和不斷增加的倡議
      • 降低Sequen床上用品的成本
      • 對個性化醫療的需求增加
      • 分析增長因素對市場預測的影響
    • 抑製器
      • 數據隱私問題
      • 高數據存儲要求
      • 分析限制因素對市場預測的影響
    • 市場機會
      • 可以預先治癒頑固性疾病
  • COVID-19的影響
  • 波特的五力分析

第5章全球市場規模和預測

  • 通過解決方案
  • 技術
  • 按應用
  • 最終用戶
  • 按地區

第6章北美市場規模和預測

  • 概述
  • 通過解決方案
  • 技術
  • 按應用
  • 最終用戶
  • 按國家
    • 美國市場規模和預測
      • 通過解決方案
      • 技術
    • 加拿大市場規模和預測

第7章歐洲市場規模和預測

  • 概述
  • 通過解決方案
  • 技術
  • 按應用
  • 最終用戶
  • 按國家
    • 英國市場規模和預測
      • 通過解決方案
      • 技術
    • 德國市場規模和預測
    • 法國市場規模和預測
    • 意大利市場規模和預測
    • 西班牙市場規模和預測

第8章亞太市場規模和預測

  • 概述
  • 通過解決方案
  • 技術
  • 按應用
  • 最終用戶
  • 按國家
    • 中國市場規模和預測
      • 通過解決方案
      • 技術
    • 日本市場規模和預測
    • 印度市場規模和預測

第9章拉丁美洲市場規模和預測

  • 概述
  • 通過解決方案
  • 技術
  • 按應用
  • 最終用戶
  • 按國家

第10章MEA市場規模和預測

  • 概述
  • 通過解決方案
  • 技術
  • 按應用
  • 最終用戶
  • 按國家

第11章競爭情況

  • 公司及其提供的產品/服務列表
  • 主要公司的競爭基準
  • 市場戰略發展

第12章公司簡介

  • Bio-Rad Laboratories Inc.
  • Agilent Technologies Inc.
  • Quest Diagnostics Inc.
  • Danaher Corporation
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd.
  • Eurofins Scientific SE
  • Pacific Biosciences of California Inc.
  • GENEWIZ Inc.
  • Psomagen Inc.
  • BGI Tech Solutions Co. Ltd.
  • Oxford Nanopore Technologies Ltd.
  • 10X Genomics Inc.
  • Eppendorf AG
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.

第13章 附錄

目錄

Title:
Genomics Market Research Report: By Solution (Consumables, Instruments, Services), Technology (PCR, Sequencing, Microarray), Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture and Animal Research), End User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies) - Global Industry Analysis and Growth Forecast to 2030.

According to a study conducted by P&S Intelligence, the global genomics market is expected to generate a revenue of $68.0 billion by 2030, increasing from $18.2 billion in 2019, progressing at a 12.7% CAGR during the forecast period (2020-2030).

The market is growing due to the increasing government initiatives and support, rising requirement for personalized medicine, and reduction in the cost of sequencing services. In terms of solution, the market is categorized into services, consumables, and instruments, among which, the consumables category dominated the market in 2019.

This can be attributed to the rising number of samples that are being processed at labs, research centers, and several other end-use settings. In addition to this, the growing number of research projects are also resulting in the rising demand for consumables. On the basis of application, the genomics market is categorized into diagnostics, agriculture and animal research, precision medicine, and drug discovery & development. Among which, the diagnostics category held the major share of the market in 2019, owing to the rising research projects related to genetic diseases, including cancer.

When technology is taken into consideration, the genomics market is classified into microarray, polymerase chain reaction, and sequencing, out of which, the sequencing classification is predicted to witness the highest CAGR during the forecast period. The demand for this technology is growing rapidly, owing to its lowering cost. As per the National Human Genome research Institute, the cost of genome sequencing was about $10,000 in the mid-2011, which decreased considerably to $1,000 in 2018. This is expected to drive the adoption of sequencing, thereby leading to the growth of the market.

North America accounted for the largest share of the market in the past, which is because of the various ongoing genomics research projects, presence of major players, and increasing investments in the industry by both government and private organizations. The Asia-Pacific region is predicted to register the highest CAGR during the forecast period, as the number of research activities in the field to genomics is growing in countries including Japan, India, and China. Both public and private organizations are providing funding for innovations in genome research.

In conclusion, the market is being driven by increasing need for personalized medicine and rising support and initiatives by governments across the globe.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Solution
    • 1.3.2 Market Segmentation by Technology
    • 1.3.3 Market Segmentation by Application
    • 1.3.4 Market Segmentation by End User
    • 1.3.5 Market Segmentation by Region
    • 1.3.6 Analysis Period
    • 1.3.7 Market Data Reporting Unit
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
    • 2.1.1 Paid
    • 2.1.2 Unpaid
  • 2.2 Primary Research
    • 2.2.1 Split of Primary Research Information
    • 2.2.2 Breakdown of Primary Research Respondents
      • 2.2.2.1 By industry participant
      • 2.2.2.2 By company type
    • 2.2.3 Breakdown of Primary Research by Company and Designation
  • 2.3 Baseline Methodology
  • 2.4 Market Size Estimation
  • 2.5 Data Triangulation
  • 2.6 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Solution
      • 4.1.1.1 Consumables
      • 4.1.1.2 Instruments
      • 4.1.1.3 Services
    • 4.1.2 By Technology
      • 4.1.2.1 PCR
      • 4.1.2.2 Sequencing
      • 4.1.2.3 Microarray
      • 4.1.2.4 Others
    • 4.1.3 By Application
      • 4.1.3.1 Diagnostics
      • 4.1.3.2 Drug discovery and development
      • 4.1.3.3 Precision medicine
      • 4.1.3.4 Agriculture and animal research
      • 4.1.3.5 Others
    • 4.1.4 By End User
      • 4.1.4.1 Research centers and academic institutes
      • 4.1.4.2 Hospitals and clinics
      • 4.1.4.3 Pharmaceutical and biotechnology companies
      • 4.1.4.4 Others
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing number of acquisitions
      • 4.2.1.2 Growing partnerships among market players
    • 4.2.2 Drivers
      • 4.2.2.1 Rising government support and initiatives
      • 4.2.2.2 Reducing cost of sequencing services
      • 4.2.2.3 Growing demand for personalized medicines
      • 4.2.2.4 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Data privacy concerns
      • 4.2.3.2 High data storage requirements
      • 4.2.3.3 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Potential to cure previously incurable diseases
  • 4.3 Impact of COVID-19
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Intensity of Rivalry
    • 4.4.4 Threat of New Entrants
    • 4.4.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

  • 5.1 By Solution
  • 5.2 By Technology
  • 5.3 By Application
  • 5.4 By End User
  • 5.5 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 Overview
  • 6.2 By Solution
  • 6.3 By Technology
  • 6.4 By Application
  • 6.5 By End User
  • 6.6 By Country
    • 6.6.1 U.S. Market Size and Forecast
      • 6.6.1.1 By solution
      • 6.6.1.2 By technology
    • 6.6.2 Canada Market Size and Forecast
      • 6.6.2.1 By solution
      • 6.6.2.2 By technology

Chapter 7. Europe Market Size and Forecast

  • 7.1 Overview
  • 7.2 By Solution
  • 7.3 By Technology
  • 7.4 By Application
  • 7.5 By End User
  • 7.6 By Country
    • 7.6.1 U.K. Market Size and Forecast
      • 7.6.1.1 By solution
      • 7.6.1.2 By technology
    • 7.6.2 Germany Market Size and Forecast
      • 7.6.2.1 By solution
      • 7.6.2.2 By technology
    • 7.6.3 France Market Size and Forecast
      • 7.6.3.1 By solution
      • 7.6.3.2 By technology
    • 7.6.4 Italy Market Size and Forecast
      • 7.6.4.1 By solution
      • 7.6.4.2 By technology
    • 7.6.5 Spain Market Size and Forecast
      • 7.6.5.1 By solution
      • 7.6.5.2 By technology

Chapter 8. APAC Market Size and Forecast

  • 8.1 Overview
  • 8.2 By Solution
  • 8.3 By Technology
  • 8.4 By Application
  • 8.5 By End User
  • 8.6 By Country
    • 8.6.1 China Market Size and Forecast
      • 8.6.1.1 By solution
      • 8.6.1.2 By technology
    • 8.6.2 Japan Market Size and Forecast
      • 8.6.2.1 By solution
      • 8.6.2.2 By technology
    • 8.6.3 India Market Size and Forecast
      • 8.6.3.1 By solution
      • 8.6.3.2 By technology

Chapter 9. LATAM Market Size and Forecast

  • 9.1 Overview
  • 9.2 By Solution
  • 9.3 By Technology
  • 9.4 By Application
  • 9.5 By End User
  • 9.6 By Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 Overview
  • 10.2 By Solution
  • 10.3 By Technology
  • 10.4 By Application
  • 10.5 By End User
  • 10.6 By Country

Chapter 11. Competitive Landscape

  • 11.1 List of Players and Their Offerings
  • 11.2 Competitive Benchmarking of Key Players
  • 11.3 Strategic Developments in the Market
    • 11.3.1 Mergers and Acquisitions
    • 11.3.2 Product and Service Launches
    • 11.3.3 Partnerships
    • 11.3.4 Other Developments

Chapter 12. Company Profiles

  • 12.1 Bio-Rad Laboratories Inc.
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Agilent Technologies Inc.
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
    • 12.2.3 Key Financial Summary
  • 12.3 Quest Diagnostics Inc.
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Key Financial Summary
  • 12.4 Danaher Corporation
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
    • 12.4.3 Key Financial Summary
  • 12.5 QIAGEN N.V.
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
    • 12.5.3 Key Financial Summary
  • 12.6 F. Hoffmann-La Roche Ltd.
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
    • 12.6.3 Key Financial Summary
  • 12.7 Eurofins Scientific SE
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
    • 12.7.3 Key Financial Summary
  • 12.8 Pacific Biosciences of California Inc.
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
    • 12.8.3 Key Financial Summary
  • 12.9 GENEWIZ Inc.
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
  • 12.10 Psomagen Inc.
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
  • 12.11 BGI Tech Solutions Co. Ltd.
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
  • 12.12 Oxford Nanopore Technologies Ltd.
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
  • 12.13 10X Genomics Inc.
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
    • 12.13.3 Key Financial Summary
  • 12.14 Eppendorf AG
    • 12.14.1 Business Overview
    • 12.14.2 Product and Service Offerings
    • 12.14.3 Key Financial Summary
  • 12.15 Thermo Fisher Scientific Inc.
    • 12.15.1 Business Overview
    • 12.15.2 Product and Service Offerings
    • 12.15.3 Key Financial Summary
  • 12.16 Illumina Inc.
    • 12.16.1 Business Overview
    • 12.16.2 Product and Service Offerings
    • 12.16.3 Key Financial Summary

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports

List of Tables  

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 COVID-19 IMPACT ANALYSIS ON DIFFERENT SECTORS
  • TABLE 5 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 6 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 7 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 8 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 9 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 10 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 11 GLOBAL GENOMICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 12 GLOBAL GENOMICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 13 GLOBAL GENOMICS MARKET, BY REGION, $M (2014-2019)
  • TABLE 14 GLOBAL GENOMICS MARKET, BY REGION, $M (2020-2030)
  • TABLE 15 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 16 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 17 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 18 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 19 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 20 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 21 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 22 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 23 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 24 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 25 U.S. GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 26 U.S. GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 27 U.S. GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 28 U.S. GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 29 CANADA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 30 CANADA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 31 CANADA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 32 CANADA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 33 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 34 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 35 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 36 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 37 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 38 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 39 EUROPE GENOMICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 40 EUROPE GENOMICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 41 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 42 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 43 U.K. GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 44 U.K. GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 45 U.K. GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 46 U.K. GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 47 GERMANY GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 48 GERMANY GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 49 GERMANY GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 50 GERMANY GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 51 FRANCE GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 52 FRANCE GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 53 FRANCE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 54 FRANCE GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 55 ITALY GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 56 ITALY GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 57 ITALY GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 58 ITALY GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 59 SPAIN GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 60 SPAIN GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 61 SPAIN GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 62 SPAIN GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 63 APAC GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 64 APAC GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 65 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 66 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 67 APAC GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 68 APAC GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 69 APAC GENOMICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 70 APAC GENOMICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 71 APAC GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 72 APAC GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 73 CHINA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 74 CHINA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 75 CHINA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 76 CHINA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 77 JAPAN GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 78 JAPAN GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 79 JAPAN GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 80 JAPAN GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 81 INDIA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 82 INDIA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 83 INDIA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 84 INDIA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 85 LATAM GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 86 LATAM GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 87 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 88 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 89 LATAM GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 90 LATAM GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 91 LATAM GENOMICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 92 LATAM GENOMICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 93 LATAM GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 94 LATAM GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 95 MEA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
  • TABLE 96 MEA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
  • TABLE 97 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 98 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 99 MEA GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 100 MEA GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 101 MEA GENOMICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 102 MEA GENOMICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 103 MEA GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 104 MEA GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 105 LIST OF PLAYERS AND THEIR OFFERINGS
  • TABLE 106 COMPETITIVE BENCHMARKING OF KEY PLAYERS
  • TABLE 107 BIO-RAD LABORATORIES INC. - AT A GLANCE
  • TABLE 108 BIO-RAD LABORATORIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 109 AGILENT TECHNOLOGIES INC. - AT A GLANCE
  • TABLE 110 AGILENT TECHNOLOGIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 111 QUEST DIAGNOSTICS INC. - AT A GLANCE
  • TABLE 112 QUEST DIAGNOSTICS INC. - KEY FINANCIAL SUMMARY
  • TABLE 113 DANAHER CORPORATION - AT A GLANCE
  • TABLE 114 DANAHER CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 115 QIAGEN N.V. - AT A GLANCE
  • TABLE 116 QIAGEN N.V. - KEY FINANCIAL SUMMARY
  • TABLE 117 F. HOFFMANN-LA ROCHE LTD. - AT A GLANCE
  • TABLE 118 F. HOFFMANN-LA ROCHE LTD. - KEY FINANCIAL SUMMARY
  • TABLE 119 EUROFINS SCIENTIFIC SE - AT A GLANCE
  • TABLE 120 EUROFINS SCIENTIFIC SE - KEY FINANCIAL SUMMARY
  • TABLE 121 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - AT A GLANCE
  • TABLE 122 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - KEY FINANCIAL SUMMARY
  • TABLE 123 GENEWIZ INC. - AT A GLANCE
  • TABLE 124 PSOMAGEN INC. - AT A GLANCE
  • TABLE 125 BGI TECH SOLUTIONS CO. LTD. - AT A GLANCE
  • TABLE 126 OXFORD NANOPORE TECHNOLOGIES LTD. - AT A GLANCE
  • TABLE 127 10X GENOMICS INC. - AT A GLANCE
  • TABLE 128 10X GENOMICS INC. - KEY FINANCIAL SUMMARY
  • TABLE 129 EPPENDORF AG - AT A GLANCE
  • TABLE 130 EPPENDORF AG - KEY FINANCIAL SUMMARY
  • TABLE 131 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 132 THERMO FISHER SCIENTIFIC INC.- KEY FINANCIAL SUMMARY
  • TABLE 133 ILLUMINA INC.- AT A GLANCE
  • TABLE 134 ILLUMINA INC.- KEY FINANCIAL SUMMARY

List of Figures

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 6 DATA TRIANGULATION APPROACH
  • FIG 7 GLOBAL GENOMICS MARKET SUMMARY
  • FIG 8 BARGAINING POWER OF BUYERS
  • FIG 9 BARGAINING POWER OF SUPPLIERS
  • FIG 10 INTENSITY OF RIVALRY
  • FIG 11 THREAT OF NEW ENTRANTS
  • FIG 12 THREAT OF SUBSTITUTES
  • FIG 13 GLOBAL GENOMICS MARKET SNAPSHOT
  • FIG 14 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
  • FIG 15 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 16 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 17 GLOBAL GENOMICS MARKET, BY END USER, $M (2014-2030)
  • FIG 18 GLOBAL GENOMICS MARKET, BY REGION, $M (2014-2030)
  • FIG 19 NORTH AMERICA GENOMICS MARKET SNAPSHOT
  • FIG 20 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
  • FIG 21 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 22 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 23 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2014-2030)
  • FIG 24 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 25 EUROPE GENOMICS MARKET SNAPSHOT
  • FIG 26 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
  • FIG 27 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 28 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 29 EUROPE GENOMICS MARKET, BY END USER, $M (2014-2030)
  • FIG 30 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 31 APAC GENOMICS MARKET SNAPSHOT
  • FIG 32 APAC GENOMICS MARKET, BY SOLUTION $M (2014-2030)
  • FIG 33 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 34 APAC GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 35 APAC GENOMICS MARKET, BY END USER, $M (2014-2030)
  • FIG 36 APAC GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 37 LATAM GENOMICS MARKET SNAPSHOT
  • FIG 38 LATAM GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
  • FIG 39 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 40 LATAM GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 41 LATAM GENOMICS MARKET, BY END USER, $M (2014-2030)
  • FIG 42 LATAM GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 43 MEA GENOMICS MARKET SNAPSHOT
  • FIG 44 MEA GENOMICS MARKET, BY SOLUTION, $M (2014-2030)
  • FIG 45 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 46 MEA GENOMICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 47 MEA GENOMICS MARKET, BY END USER, $M (2014-2030)
  • FIG 48 MEA GENOMICS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 49 BIO-RAD LABORATORIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 50 AGILENT TECHNOLOGIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 51 QUEST DIAGNOSTICS INC. - REVENUE SPLIT BY DIVISION (2019)
  • FIG 52 DANAHER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 53 QIAGEN N.V. - REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2019)
  • FIG 54 F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
  • FIG 55 EUROFINS SCIENTIFIC SE - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 56 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - REVENUE SPLIT BY CATEGORY AND GEOGRAPHY (2019)
  • FIG 57 10X GENOMICS INC. - REVENUE SPLIT BY CATEGORY AND GEOGRAPHY (2019)
  • FIG 58 EPPENDORF AG - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 59 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 60 ILLUMINA INC. - REVENUE SPLIT BY PRODUCTS AND SERVICES AND GEOGRAPHY (2019)